The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.
 
Kim N. Chi
No Relationships to Disclose
 
Dana E. Rathkopf
No Relationships to Disclose
 
Matthew Raymond Smith
No Relationships to Disclose
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Merck; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
 
Gerhardt Attard
No Relationships to Disclose
 
David Olmos
No Relationships to Disclose
 
Ji Youl Lee
No Relationships to Disclose
 
Eric Jay Small
Stock and Other Ownership Interests - Fortis; Harpoon Therapeutics; Teon Therapeutics
Honoraria - Janssen; Johnson & Johnson
Consulting or Advisory Role - Beigene; Fortis; Fortis; Janssen Oncology; Teon Therapeutics; Tolero Pharmaceuticals; Ultragenyx Pharmaceuticals
Research Funding - Janssen (Inst)
Travel, Accommodations, Expenses - Janssen
 
Andrea Juliana Gomes
No Relationships to Disclose
 
Guilhem Roubaud
No Relationships to Disclose
 
Marniza Saad
No Relationships to Disclose
 
Bogdan Zurawski
No Relationships to Disclose
 
Valerii Sakalo
No Relationships to Disclose
 
Gary Mason
No Relationships to Disclose
 
Adam del Corral
No Relationships to Disclose
 
George C. Wang
No Relationships to Disclose
 
Daphne Wu
No Relationships to Disclose
 
Brooke Diorio
No Relationships to Disclose
 
Angela Mennicke Lopez- Gitlitz
No Relationships to Disclose
 
Shahneen Kaur Sandhu
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck Serono (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb/Roche (Inst); Merck Sharp & Dohme (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst)